Cancer
Cancer Ongoing 2020 Florida

EA1183

FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE

Trial overview

Disease
Breast cancer treatment and diagnosis
Topic
EA1183
Description
Primary Objective Evaluate the performance of FDG-PET/CT response criteria (modified PERCIST complete, partial and stable metabolic disease versus progressive metabolic disease) as a binary predictor of PFS in patients with BD MBC treated with systemic therapy
Physicians

Dr. Mohammad Jahanzeb

MD, FACP, FASCO

Medical Oncologist

Works at 3 centers.

Dr. Edgardo Santos

MD

Medical Oncologist

Works at 3 centers.